DEBORAH STAPEL: Open Payments
NPI 1316910706 · FORT WORTH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$12,835 in 174 payments from 32 companies in 2025. Trend: 2023 $9,924 · 2024 $12,467 · 2025 $12,835
Speaker / faculty: $9,129Food & beverage: $3,364Education: $193Consulting: $150
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 56 | $10,174 |
| Teva Pharmaceuticals USA, Inc. | 7 | $280 |
| Biogen, Inc. | 8 | $267 |
| Eisai Inc. | 8 | $225 |
| Vanda Pharmaceuticals Inc. | 8 | $221 |
| Grifols USA, LLC | 7 | $215 |
| PFIZER INC. | 11 | $198 |
| Lundbeck LLC | 19 | $163 |
| Amneal Pharmaceuticals LLC | 6 | $119 |
| UCB, Inc. | 4 | $93 |
Products named: UBRELVY, QULIPTA, BOTOX, Leqembi, PONVORY, Gamunex-C, NURTEC ODT, TYSABRI.
Industry payments across TX — which companies pay providers there.
